Putnam Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Putnam Investments’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$415K	Sell	6,399 -55,316	-90%	-$3.33M	﹤0.01%	984
2023 Q3	$4.04M	Buy	61,715 +55,714	+928%	+$3.51M	0.01%	477
2023 Q2	$349K	Sell	6,001 -182	-3%	-$11.5K	﹤0.01%	1042
2023 Q1	$382K	Buy	6,183 +431	+7%	+$25.9K	﹤0.01%	1002
2022 Q4	$366K	Sell	5,752 -3	-0.1%	-$218	﹤0.01%	1025
2022 Q3	$418K	Sell	5,755 -102	-2%	-$7.59K	﹤0.01%	974
2022 Q2	$398K	Sell	5,857 -70	-1%	-$5.03K	﹤0.01%	996
2022 Q1	$537K	Sell	5,927 -422	-7%	-$34.5K	﹤0.01%	982
2021 Q4	$580K	Buy	+6,349	New	+$544K	﹤0.01%	930

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's NARI Position: Q4 2023 in Review

Putnam Investments reduced its Inari Medical, Inc. Common Stock (NARI) stake by 90% in Q4 2023, selling an estimated $3.33M and leaving 6,399 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Putnam Investments first reported a position in NARI in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.04M in Q3 2023. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

Putnam Investments held 6,399 shares of Inari Medical, Inc. Common Stock worth $415K as of Q4 2023.
Putnam Investments sold 55,316 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $3.33M.
Inari Medical, Inc. Common Stock made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #984 holding.
Putnam Investments first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and has held it in 9 quarters since.
Putnam Investments's Inari Medical, Inc. Common Stock position peaked at $4.04M in Q3 2023.
252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.